Access
To read this story in full you will need to login or make a payment (see right).
Technology Feature
Nature 425, 871 (23 October 2003) | doi:10.1038/425871a
High throughput goes 3D
High-throughput analysis of cellular processes is now entering the mainstream for drug discovery, but Pittsburgh-based Cellomics has been working in this area for some time. Founded in 1996 to focus on the automated analysis of cell arrays, Cellomics offers an integrated package of imaging platforms with full environmental control, bioassays and bioinformatics and analysis software.
To read this story in full you will need to login or make a payment (see right).